Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats-Reference-Cited by-同舟云学术

Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats

Published:2007-12 Issue:1-3 Volume:577 Page:203-210
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Arreola-Espino Rosaura,Urquiza-Marín Héctor,Ambriz-Tututi Mónica,Araiza-Saldaña Claudia Ivonne,Caram-Salas Nadia L.,Rocha-González Héctor I.,Mixcoatl-Zecuatl Teresa,Granados-Soto Vinicio

Publisher

Elsevier BV

Subject

Pharmacology

Reference54 articles.

1. Effects of melatonin on oxidative–antioxidative status of tissues in streptozotocin-induced diabetic rats;Aksoy;Cell Biochem. Funct.,2003

2. Evidence that beta-endorphin is an agonist at bovine pineal delta-opioid receptors;Aloyo;Eur. J. Pharmacol.,1995

3. Ambriz-Tututi, M., Granados-Soto, V., in press. Oral and spinal melatonin reduces tactile allodynia in rats via activation of MT2 and opioid receptors. Pain, in press.

4. Oxidative stress in streptozotocin-induced diabetic rats: effects of garlic oil and melatonin;Anwar;Comp. Biochem. Physiol. A Mol. Integr. Physiol.,2003

5. Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats;Araiza-Saldaña;Eur. J. Pharmacol.,2005

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Times Beach;Encyclopedia of Toxicology;2024

2. Melatonin Improves Mitochondrial Dysfunction and Attenuates Neuropathic Pain by Regulating SIRT1 in Dorsal Root Ganglions;Neuroscience;2023-12

3. Supraspinal melatonin MT ₂ receptor agonism alleviates pain via a neural circuit that recruits mu opioid receptors;Journal of Pineal Research;2022-09-07

4. The neuroprotective effects of melatonin against diabetic neuropathy: A systematic review of non-clinical studies;Frontiers in Pharmacology;2022-08-31

5. New Advances on Pathophysiology of Diabetes Neuropathy and Pain Management: Potential Role of Melatonin and DPP-4 Inhibitors;Frontiers in Pharmacology;2022-04-12